Petros Pharmaceuticals
PTPI
#10570
Rank
ยฃ0.41 M
Marketcap
ยฃ0.009715
Share price
8.33%
Change (1 day)
-99.86%
Change (1 year)

Revenue for Petros Pharmaceuticals (PTPI)

Revenue in 2025 (TTM): ยฃ1.75 Million

According to Petros Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ1.72 Million. In 2024 the company made a revenue of ยฃ1.83 Million a decrease over the revenue in the year 2023 that were of ยฃ4.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Petros Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.75 M-4.23%
2024 ยฃ1.83 M-59.87%
2023 ยฃ4.57 M-7.73%
2022 ยฃ4.95 M-14.41%
2021 ยฃ5.78 M-17.49%
2020 ยฃ7.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 5,943.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas